S L Morris

1.3k total citations
34 papers, 1.1k citations indexed

About

S L Morris is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, S L Morris has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 19 papers in Infectious Diseases and 15 papers in Molecular Biology. Recurrent topics in S L Morris's work include Mycobacterium research and diagnosis (21 papers), Tuberculosis Research and Epidemiology (18 papers) and Bacteriophages and microbial interactions (9 papers). S L Morris is often cited by papers focused on Mycobacterium research and diagnosis (21 papers), Tuberculosis Research and Epidemiology (18 papers) and Bacteriophages and microbial interactions (9 papers). S L Morris collaborates with scholars based in United States, France and South Korea. S L Morris's co-authors include D A Rouse, J N Hansen, Frank M. Collins, G H Bai, Zhi Li, Christine A. Kelley, S D Chaparas, Arturo Panduro, Leopoldo Portillo-Gómez and Robert H. Heflich and has published in prestigious journals such as Journal of Biological Chemistry, Applied and Environmental Microbiology and Journal of Bacteriology.

In The Last Decade

S L Morris

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S L Morris United States 18 672 643 326 224 133 34 1.1k
P. S. Jackett United Kingdom 17 553 0.8× 463 0.7× 278 0.9× 131 0.6× 208 1.6× 23 936
Omar Vandal United States 12 660 1.0× 498 0.8× 417 1.3× 109 0.5× 107 0.8× 13 1.0k
Pascale Peyron France 13 785 1.2× 629 1.0× 648 2.0× 208 0.9× 323 2.4× 15 1.6k
Wanyan Deng China 18 465 0.7× 460 0.7× 721 2.2× 111 0.5× 266 2.0× 44 1.3k
Benjamin G. Schroeder United States 10 974 1.4× 774 1.2× 680 2.1× 134 0.6× 129 1.0× 11 1.6k
Gauranga Mukhopadhyay India 22 267 0.4× 295 0.5× 460 1.4× 126 0.6× 88 0.7× 41 1.1k
Peter Kolonoski United States 19 722 1.1× 831 1.3× 186 0.6× 147 0.7× 167 1.3× 27 1.1k
Mridula Bose India 20 936 1.4× 780 1.2× 419 1.3× 341 1.5× 113 0.8× 59 1.4k
Yaqi Zhu China 9 657 1.0× 470 0.7× 457 1.4× 99 0.4× 149 1.1× 33 1.1k
Michael V. Tullius United States 16 414 0.6× 322 0.5× 501 1.5× 57 0.3× 170 1.3× 19 1.0k

Countries citing papers authored by S L Morris

Since Specialization
Citations

This map shows the geographic impact of S L Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S L Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S L Morris more than expected).

Fields of papers citing papers by S L Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S L Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S L Morris. The network helps show where S L Morris may publish in the future.

Co-authorship network of co-authors of S L Morris

This figure shows the co-authorship network connecting the top 25 collaborators of S L Morris. A scholar is included among the top collaborators of S L Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S L Morris. S L Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coyle, Joseph T., et al.. (2015). The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity. International Journal of Critical Illness and Injury Science. 5(1). 9–9. 4 indexed citations
2.
Kolibab, Kristopher, Amy Yang, Marcela Parra, Steven C. Derrick, & S L Morris. (2013). Time to Detection of Mycobacterium tuberculosis Using the MGIT 320 System Correlates with Colony Counting in Preclinical Testing of New Vaccines. Clinical and Vaccine Immunology. 21(3). 453–455. 13 indexed citations
4.
Brickey, W. June, et al.. (2003). Susceptibility of Mice Deficient in the MHC Class II Transactivator to Infection with Mycobacterium tuberculosis. Scandinavian Journal of Immunology. 58(1). 15–22. 22 indexed citations
5.
Brennan, Michael J., Frank M. Collins, & S L Morris. (1999). Propelling novel vaccines directed against tuberculosis through the regulatory process. Tubercle and Lung Disease. 79(3). 145–151. 12 indexed citations
6.
Li, Zhi, Christine A. Kelley, Frank M. Collins, D A Rouse, & S L Morris. (1998). Expression of katG in Mycobacterium tuberculosis Is Associated with Its Growth and Persistence in Mice and Guinea Pigs. The Journal of Infectious Diseases. 177(4). 1030–1035. 154 indexed citations
7.
Rouse, D A, et al.. (1997). Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 41(9). 2057–2058. 89 indexed citations
8.
Morris, S L & D A Rouse. (1996). The genetics of multiple drug resistance in Mycobacterium tuberculosis and the Mycobacterium avium complex. Research in Microbiology. 147(1-2). 68–73. 5 indexed citations
9.
Dawes, Stephanie S., Robert J. Crouch, S L Morris, & Valerie Mizrahi. (1995). Cloning, sequence analysis, overproduction in Escherichia coli and enzymatic characterization of the RNase HI from Mycobacterium smegmatis. Gene. 165(1). 71–75. 15 indexed citations
10.
Rouse, D A, et al.. (1995). A highly immunogenic putative Mycobacterium kansasii lipoprotein. Microbiology. 141(10). 2705–2712. 5 indexed citations
11.
Rouse, D A & S L Morris. (1995). Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infection and Immunity. 63(4). 1427–1433. 52 indexed citations
12.
Morris, S L, et al.. (1992). The catalase-peroxidase of Mycobacterium intracellulare: nucleotide sequence analysis and expression in Escherichia coli. Journal of General Microbiology. 138(11). 2363–2370. 37 indexed citations
13.
Morris, S L, et al.. (1992). Skin testing with recombinant Mycobacterium intracellulare antigens. Tubercle and Lung Disease. 73(3). 129–133. 4 indexed citations
14.
Morris, S L, Luiz E. Bermudez, & S D Chaparas. (1991). Mycobacterium avium complex disease in patients with AIDS: seroreactivity to native and recombinant mycobacterial antigens. Journal of Clinical Microbiology. 29(12). 2715–2719. 15 indexed citations
15.
Morris, S L. (1991). Antigens of the Mycobacterium avium, Micobacterium intracellulare complex. European Journal of Epidemiology. 7(4). 328–338. 2 indexed citations
16.
Morris, S L, D A Rouse, David Hussong, & S D Chaparas. (1990). Isolation and characterization of recombinant lambda gt11 bacteriophages expressing four different Mycobacterium intracellulare antigens. Infection and Immunity. 58(1). 17–20. 13 indexed citations
17.
Morris, S L, et al.. (1990). Characterisation of plasmids extracted from AIDS—associated mycobacterium avium isolates. Tubercle. 71(3). 181–185. 10 indexed citations
18.
Morris, S L, D A Rouse, David Hussong, & S D Chaparas. (1988). Isolation and characterization of a recombinant lambda gt11 bacteriophage which expresses an immunoreactive Mycobacterium intracellulare protein in Escherichia coli. Infection and Immunity. 56(12). 3026–3031. 18 indexed citations
19.
Morris, S L & Robert H. Heflich. (1984). A comparison of the toxic and SCE-inducing effects of inhibitors of ADP-ribosyl transferase in Chinese hamster ovary cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 126(1). 63–71. 36 indexed citations
20.
Morris, S L & J N Hansen. (1981). Bacterial spore components which enhance the bacteriostatic effectiveness of S-nitrosothiol. Applied and Environmental Microbiology. 42(6). 958–962. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026